Assembly Biosciences (ASMB) Non-Current Deferred Tax Liability (2014 - 2021)

Assembly Biosciences' Non-Current Deferred Tax Liability history runs 8 years deep, the most recent figure standing at $2.5 million for Q3 2021.

• In Q3 2021, Non-Current Deferred Tax Liability changed 0.0% year-over-year to $2.5 million; the TTM figure through Sep 2021 stood at $2.5 million (changed 0.0% YoY), while the FY2020 annual figure was $2.5 million, changed 0.0% from the prior year.
• Non-Current Deferred Tax Liability was $2.5 million for Q3 2021 at Assembly Biosciences, roughly flat from $2.5 million in the prior quarter.
• In the past five years, Non-Current Deferred Tax Liability ranged from a high of $3.3 million in Q4 2018 to a low of $2.1 million in Q4 2017.
• Historically, Non-Current Deferred Tax Liability has averaged $2.7 million across 5 years, with a median of $2.5 million in 2019.
• The sharpest annual moves came in 2017 and 2018: Non-Current Deferred Tax Liability slumped 80.79% in 2017, then surged 52.25% in 2018.
• A 5-year view of Non-Current Deferred Tax Liability shows it stood at $2.1 million in 2017, then soared by 52.25% to $3.3 million in 2018, then decreased by 22.17% to $2.5 million in 2019, then changed by 0.0% to $2.5 million in 2020, then changed by 0.0% to $2.5 million in 2021.
• The last three Non-Current Deferred Tax Liability figures came in at $2.5 million (Q3 2021), $2.5 million (Q2 2021), and $2.5 million (Q1 2021), per Business Quant data.